|
WO2020087077A1
|
|
Biomarkers of metap2 inhibitors and applications thereof
|
|
EP3402529A1
|
|
Treatment for tumors driven by metabolic dysfunction
|
|
EP3386956A1
|
|
Fumagillol derivatives and polymorphs thereof
|
|
US2017258925A1
|
|
Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
|
|
US2015141580A1
|
|
Optimized drug conjugates
|
|
CN105431426A
|
|
METAP2 inhibitors and methods of treating obesity
|
|
CN107141410A
|
|
The MetAP2 inhibitor and its treatment method of application of polymeric conjugation
|
